Value & Dossier – Your Reimbursement Specialists
HS Value & Dossier GmbH
We are offering market access and reimbursement solutions for the different product life cycle phases
From study design to price negotiation
A new product has only one chance to enter the market successfully
We help you with passion to master the challenges of health policy
Market Access and Reimbursement for Pharmaceuticals and Medical Devices
Market access and reimbursement of drugs and medical devices are governed by complex legal and regulatory requirements. When initial market access is granted, a benefit assessment is required on behalf of the responsible institutions, which either represents an entry barrier in terms of a fourth hurdle or serves as a prerequisite for price negotiations. It is generally assumable that a „Health Technology Assessment“, in terms of a benefit assessment according to the criteria of evidence-based medicine, is necessary for all medical services that are newly included in the service catalogue of statutory health insurers. However, the processes may differ between different products and perforamance areas.
Market Access and Reimbursement of Drugs in Germany
Market Access and Reimbursement of Medical Devices
About HS Value & Dossier
HS Value & Dossier GmbH advises innovative pharmaceutical and biotechnology companies in the AMNOG process. Based on our long and valueable expertise, our qualified employees and our versatile partners, we support you in strategy development, in preparing your benefit dossier for the G-BA evaluation, and in price negotiations with the GKV-Spitzenverband. Both the motivation and the objectives are always the optimized reimbursement for your new product. Our focus is on detailed process experience and innovative, interdisciplinary approaches.
„We offer individual and business-specific solutions which focus on the product’s value and implement them appropriately in the required benefit dossiers“
Dr. Willi Schnorpfeil